SAKK

SAKK conducts clinical trials for adult patients on a national level. The group also contributes to many international studies conducted by other research groups. The SAKK participates in all trials of the International Breast Cancer Study Group (IBCSG), a group with strong roots in Switzerland which has its Coordinating Center in Bern.
The nucleus of the SAKK was initiated in 1965 by the cooperation of divisions of hematology and oncology at the University Hospitals of Zurich, Geneva and Bern. Other newly formed tumor centers – so called SAKK regions - joined the organization over the years. Today SAKK activities cover the whole national territory.

Contact Details: Coordinating Center Effingerstrasse 40 Bern CH - 3008 Switzerland Tel: 41 31 389 9191 Fax: 41 31 389 9200 Email: sakkcc@sakk.ch WWW: www.sakk.ch/

Recent Publications by SAKK:
Adjuvant perioperative portal vein or peripheral intravenous chemotherapy for potentially curative colorectal cancer: long-term results of a randomized controlled trial. BACKGROUND AND AIMS: The perioperative use of a single course adjuvant...	9th August, 2008	Swiss Group for Clinical Cancer Research (SAKK), Effingerstrasse 40,	Int J Colorectal Dis. 2008 Aug 8. DOI Direct Link
Individual versus standard quality of life assessment in a phase II clinical trial in mesothelioma patients: Feasibility and responsiveness to clinical changes. BACKGROUND: In patients with malignant pleural mesothelioma undergoing a...	25th April, 2008	Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center,	Lung Cancer. 2008 Apr 21. DOI Direct Link
Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer. BACKGROUND: Extracapsular tumor spread (ECS) has been identified as a...	4th April, 2008	Institut fur Radiotherapie, Klinik Hirslanden and Swiss Group for Clinical	Ann Oncol. 2008 Aug;19(8):1393-401. Epub 2008 Apr 2. DOI Direct Link
Sequential high dose chemotherapy as initial treatment for aggressive sub-types of non-Hodgkin lymphoma: results of the international randomized phase III trial (MISTRAL). INTRODUCTION: Sequential high dose (SHiDo) chemotherapy with stem cell...	3rd July, 2007	SAKK (Swiss Group for Clinical Cancer Research), Bern, Switzerland.	Ann Oncol. 2006 Oct;17(10):1546-52. Epub 2006 Aug 3. DOI Direct Link
Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00). BACKGROUND: The aim of this study was to evaluate the efficacy and...	6th April, 2007	Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.	Ann Oncol. 2007 Jan;18(1):64-9. Epub 2006 Oct 9. DOI Direct Link
→View more SAKK research publications.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 180 times since April 2007, the link to the organisation's website has been followed 19 times

Search for more companies in Bern

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for SAKK